<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/215924.xml</link>
<description>PRWeb.com Press Release Feed - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Microencapsulation of Living Cells to Treat Diabetes? Austrianova Validates Commercial Potential of its Proprietary Encapsulation Technology </title>
     <link>http://www.prweb.com/releases/2006/08/prweb430671.htm</link><description>   <![CDATA[ <P>Austrianova Biotechnology has successfully demonstrated the feasibility of encapsulating an insulin-producing cell line in cellulose sulphate on the basis of its proprietary encapsulation technology. A new study published by an academic partner - a clinical research group at the Medical University Graz, Austria - in the scientific journal &#8220;Xenotransplantation&quot; (1) demonstrates that the microencapsulated cells do not differ in glucose-dependent cell proliferation, insulin secretion or glucose uptake from non-microencapsulated cells. (PRWeb Aug 31, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/08/prweb430671.htm">http://www.prweb.com/releases/2006/08/prweb430671.htm</a></P>]]>
                </description><pubDate>Thu, 31 Aug 2006 07:00:00 GMT</pubDate>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/08/prweb430671.htm</guid>
        </item>
</channel>
</rss>